Cargando…

Azacytidine Treatment for VEXAS Syndrome

Detalles Bibliográficos
Autores principales:	Raaijmakers, Marc H. G. P., Hermans, Maud, Aalbers, Anna, Rijken, Melissa, Dalm, Virgil A. S. H., van Daele, Paul, Valk, Peter J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598219/ https://www.ncbi.nlm.nih.gov/pubmed/34805767 http://dx.doi.org/10.1097/HS9.0000000000000661

Ejemplares similares

Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
por: Manzoni, Marco, et al.
Publicado: (2022)

VEXAS syndrome
por: Grayson, Peter C., et al.
Publicado: (2021)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

VEXAS-Syndrom
por: Zeeck, M., et al.
Publicado: (2022)

Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
por: Rabut, Audrey, et al.
Publicado: (2023)

Intrapatient competition of VEXAS syndrome and CML clones
por: Djerbi, Nadia, et al.
Publicado: (2023)

Thrombosis in VEXAS syndrome
por: Oo, Thet Mon, et al.
Publicado: (2021)

VEXAS Syndrome—Review
por: Zhang, Yue, et al.
Publicado: (2023)

Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim
por: Al-Hakim, Adam, et al.
Publicado: (2023)

Myelodysplastic Syndrome Associated With Auto-Immune Inflammatory Disease in VEXAS Syndrome
por: Thomas, Vibha Taneja, et al.
Publicado: (2021)

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome
por: Lacombe, Valentin, et al.
Publicado: (2022)

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
por: Poulter, James A., et al.
Publicado: (2021)

VEXAS syndrome with cutaneous nodules
por: Argobi, Yahya
Publicado: (2021)

Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis
por: Karadeniz, Hazan, et al.
Publicado: (2023)

Reviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment
por: Both, Tim, et al.
Publicado: (2017)

Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome
por: Faurel, Alyx, et al.
Publicado: (2023)

VEXAS syndrome: a diagnostic puzzle
por: Ruffer, Nikolas, et al.
Publicado: (2023)

Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome
por: Ding, Yanna, et al.
Publicado: (2023)

The First Korean Case of VEXAS Syndrome Caused by a UBA1 Somatic Variant
por: Yoon, Jihoon G., et al.
Publicado: (2023)

VEXAS Syndrome: A Novelty in MDS Landscape
por: Templé, Marie, et al.
Publicado: (2022)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
por: Austestad, Janne, et al.
Publicado: (2023)

Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
por: Raj, Kavita, et al.
Publicado: (2006)

UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia
por: Gurnari, Carmelo, et al.
Publicado: (2022)

Vexas: A new syndrome not always associated with hemopathy
por: Thomas, Benoît, et al.
Publicado: (2021)

Vasculitis associated with VEXAS syndrome: A literature review
por: Watanabe, Ryu, et al.
Publicado: (2022)

Recurrent superior orbital fissure syndrome associated with VEXAS syndrome
por: Myint, Katie, et al.
Publicado: (2023)

SARS-CoV-2-induced venous thromboembolism in a patient with VEXAS syndrome
por: Lucchino, Bruno, et al.
Publicado: (2023)

Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome
por: Vitale, Antonio, et al.
Publicado: (2022)

VEXAS syndrome: a newly discovered systemic rheumatic disorder
por: Kucharz, Eugenisz J.
Publicado: (2023)

Sandostatin therapy in patients with chronic sarcoidosis
por: Timmermans, Wilhelmina M.C., et al.
Publicado: (2017)

VEXAS syndrome in a female patient with constitutional 45,X (Turner syndrome)
por: Stubbins, Ryan J., et al.
Publicado: (2021)

Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome
por: Matsumoto, Haruki, et al.
Publicado: (2022)

Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome
por: Staels, Frederik, et al.
Publicado: (2021)

VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
por: Vitale, Antonio, et al.
Publicado: (2023)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome
por: Pozdniakova, Helen, et al.
Publicado: (2023)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
por: Rohon, Peter, et al.
Publicado: (2012)

Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)

Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
por: Mascaro, Jose Manuel, et al.
Publicado: (2023)

Adverse Reaction to COVID-19 mRNA Vaccination in a Patient With VEXAS Syndrome
por: Ciprian, Giulio
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qv3mueku7pae9qq8qcmlk5qr8v